BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24115652)

  • 1. Translational vitreous proteomics.
    Mahajan VB; Skeie JM
    Proteomics Clin Appl; 2014 Apr; 8(3-4):204-8. PubMed ID: 24115652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass Spectrometry-Based Vitreous Proteomics: Validated Methods and Analysis Pipeline.
    Weber S; Carruthers N; Gates C; Zhao Y; Sundstrom J
    Methods Mol Biol; 2023; 2678():157-167. PubMed ID: 37326711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug repositioning using personalized proteomics of liquid biopsies.
    Velez G; Bassuk AG; Colgan D; Tsang SH; Mahajan VB
    JCI Insight; 2017 Dec; 2(24):. PubMed ID: 29263305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of differentially expressed proteins in vitreous humor of patients with retinoblastoma using iTRAQ-coupled ESI-MS/MS approach.
    Naru J; Aggarwal R; Singh U; Mohanty AK; Bansal D; Mangat N; Kakkar N; Agnihotri N
    Tumour Biol; 2016 Oct; 37(10):13915-13926. PubMed ID: 27488116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitreous proteomic analysis of proliferative vitreoretinopathy.
    Yu J; Liu F; Cui SJ; Liu Y; Song ZY; Cao H; Chen FE; Wang WJ; Sun T; Wang F
    Proteomics; 2008 Sep; 8(17):3667-78. PubMed ID: 18752205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy.
    Gao BB; Chen X; Timothy N; Aiello LP; Feener EP
    J Proteome Res; 2008 Jun; 7(6):2516-25. PubMed ID: 18433156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic interactions in the mouse vitreous-retina complex.
    Skeie JM; Mahajan VB
    PLoS One; 2013; 8(11):e82140. PubMed ID: 24312404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untangling the Extracellular Matrix of Idiopathic Epiretinal Membrane: A Path Winding among Structure, Interactomics and Translational Medicine.
    Bianchi L; Altera A; Barone V; Bonente D; Bacci T; De Benedetto E; Bini L; Tosi GM; Galvagni F; Bertelli E
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitreous proteomics and diabetic retinopathy.
    Walia S; Clermont AC; Gao BB; Aiello LP; Feener EP
    Semin Ophthalmol; 2010; 25(5-6):289-94. PubMed ID: 21091014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New exploration of treatment target for proliferative diabetic retinopathy based on iTRAQ LC-MS/MS Proteomics].
    Wen DJ; Ren XJ; Dong LJ; He Y; Li XR
    Zhonghua Yan Ke Za Zhi; 2019 Oct; 55(10):769-776. PubMed ID: 31607066
    [No Abstract]   [Full Text] [Related]  

  • 11. The upregulation of zinc finger protein 670 and prostaglandin D2 synthase in proliferative vitreoretinopathy.
    Kuo HK; Chen YH; Huang F; Wu YC; Shiea J; Wu PC
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):205-13. PubMed ID: 25940552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular interactions in the retinal basement membrane system: a proteomic approach.
    Balasubramani M; Schreiber EM; Candiello J; Balasubramani GK; Kurtz J; Halfter W
    Matrix Biol; 2010 Jul; 29(6):471-83. PubMed ID: 20403434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometry-based characterization of the vitreous phosphoproteome.
    Tamburro D; Facchiano F; Petricoin EF; Liotta LA; Zhou W
    Proteomics Clin Appl; 2010 Nov; 4(10-11):839-46. PubMed ID: 21137027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical platforms in vitreoretinal proteomics.
    Cehofski LJ; Mandal N; Honoré B; Vorum H
    Bioanalysis; 2014; 6(22):3051-66. PubMed ID: 25496257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insoluble interphotoreceptor matrix in human vitreous after rhegmatogenous retinal detachment.
    Russell SR; Hageman GS
    Am J Ophthalmol; 1997 Mar; 123(3):386-91. PubMed ID: 9063249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proliferative vitreoretinopathy--selected issues concerning morphology and pathophysiology].
    Laudańska-Olszewska I; Omulecki W
    Klin Oczna; 2006; 108(1-3):87-9. PubMed ID: 16883949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digging Deeper for the Eye Proteome in Vitreous Substructures: A High-Resolution Proteome Map of the Normal Human Vitreous Base.
    Mohanty V; Pinto SM; Subbannayya Y; Najar MA; Murthy KB; Prasad TSK; Murthy KR
    OMICS; 2020 Jun; 24(6):379-389. PubMed ID: 32496972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor levels in the vitreous of patients with proliferative vitreoretinopathy.
    Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
    Am J Ophthalmol; 2000 May; 129(5):678-80. PubMed ID: 10844070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic insight into the molecular function of the vitreous.
    Skeie JM; Roybal CN; Mahajan VB
    PLoS One; 2015; 10(5):e0127567. PubMed ID: 26020955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and localization of major soluble vitreous proteins in human ocular tissue.
    Wu CW; Sauter JL; Johnson PK; Chen CD; Olsen TW
    Am J Ophthalmol; 2004 Apr; 137(4):655-61. PubMed ID: 15059704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.